Opendata, web and dolomites

EpiShuttle 2.0 SIGNED

EpiShuttle: Isolation and Transportation of Infectious Disease Patients

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 EpiShuttle 2.0 project word cloud

Explore the words cloud of the EpiShuttle 2.0 project. It provides you a very rough idea of what is the project "EpiShuttle 2.0" about.

epiguard    capital    infectious    specialized    company    globally    security    travelling    diseases    risk    faced    epishuttle    gas    representing    labour    patterns    doctors    brazil    launched    usa    tuberculosis    combining    professionals    thousand    group    partnering    medical    ebola    events    founded    outside    worldwide       drc    protection    clearance    gold    virus    mers    manner    positive    size    west    investment    treatment    outbreaks    world    leap    disease    demonstrated    polycarbonate    handle    africa    infected    sius    larger    isolate    11    sars    siu    77    recommends    cdc    catastrophe    market    complete    least    resistant    regulatory    claimed    bill    opportunity    madagascar    modern    patient    first    care    standard    epidemic    people    2015    compromising    hard    re    health    eur    team    zika    12    engineering    contagious    plague    emergency    isolation    asia    class    disinfection    plus    society    patients    reusable    wants    person    workflow    2014    solution    units    position    congo    pulmonary    global    risks    million    expand    china    economic    transport    lives   

Project "EpiShuttle 2.0" data sheet

The following table provides information about the project.

Coordinator
EPIGUARD AS 

Organization address
address: TORSNESVEIEN 210
city: GAMLE FREDRIKSTAD
postcode: 1634
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Norway [NO]
 Total cost 3˙565˙000 €
 EC max contribution 2˙495˙500 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-2
 Funding Scheme SME-2
 Starting year 2019
 Duration (year-month-day) from 2019-05-01   to  2021-10-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    EPIGUARD AS NO (GAMLE FREDRIKSTAD) coordinator 2˙495˙500.00

Map

 Project objective

The Problem: An increasing number of outbreaks with infectious diseases are seen globally. Ebola has claimed at least 77 lives in DRC (Congo) so far this year and over 11 thousand people West Africa in 2014. Other recent outbreaks are the SARS-epidemic, the MERS-cases in Asia, multi-resistant tuberculosis and the pulmonary Plague epidemic in Madagascar, Zika virus in Brazil, etc. Each of these events demonstrated the large health, economic and security risks associated with infectious disease outbreaks. The travelling patterns of our modern society increases the risk of a global “catastrophe”. To handle outbreaks, the CDC highly recommends the use of specialized isolation units (SIU) to isolate and transport the infected patients. The Solution: EpiGuard was founded in 2015 by a group of medical doctors that faced the challenge of managing Ebola patients on the field. After 3 years and ~5 million EUR of capital and labour investment, the company has recently launched into EU market the EpiShuttle solution – the world-first hard-top (polycarbonate), reusable SIU, representing a leap forward against the state of the art. The EpiShuttle is a one-person SIU, providing complete protection from contagious diseases, without compromising advanced treatment and care to the patient. The Opportunity: Partnering with a world-class design and engineering team, EpiGuard wants to position EpiShuttle as the gold standard for SIUs in the emergency workflow. EpiShuttle targets a 12 Bill. EUR market opportunity worldwide. Although the response from medical professionals has been positive, to fully exploit the market potential, there is a need for combining modern gas disinfection technology with EpiShuttle to allow re-use in a cost effective manner. Further, to expand the market outside Europe, regulatory clearance in USA and China plus a larger size unit for the USA market are needed.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "EPISHUTTLE 2.0" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "EPISHUTTLE 2.0" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

DNA DS (2019)

DNA Data storage

Read More  

Keelcrab (2019)

Keelcrab the Drone for an automated hull cleaning: fast & essential

Read More  

DeltaQon (2019)

IOT and cloud computing for online medical analysis service platform

Read More